Related references
Note: Only part of the references are listed.Concurrent inactivating mutations and expression losses of RGS2, HNF1A, and CAPN12 candidate tumor suppressor genes in colon cancers
Jae Woong Kim et al.
PATHOLOGY RESEARCH AND PRACTICE (2023)
Molecular Pathology of Skin Melanoma: Epidemiology, Differential Diagnostics, Prognosis and Therapy Prediction
Jozsef Timar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Deleterious AHNAK2 Mutation as a Novel Biomarker for Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
Yanan Cui et al.
FRONTIERS IN ONCOLOGY (2022)
Bone Morphogenetic Protein Signaling in Cancer; Some Topics in the Recent 10 Years
Shogo Ehata et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)
Identification of fusions with potential clinical significance in melanoma
Jakob M. T. Moran et al.
MODERN PATHOLOGY (2022)
Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study
Li Luo et al.
PIGMENT CELL & MELANOMA RESEARCH (2022)
A bioinformatics analysis: ZFHX4 is associated with metastasis and poor survival in ovarian cancer
Shuai Zong et al.
JOURNAL OF OVARIAN RESEARCH (2022)
Titin Mutation Is Associated With Tumor Mutation Burden and Promotes Antitumor Immunity in Lung Squamous Cell Carcinoma
Xiaona Xie et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial
Patricia M. LoRusso et al.
PLOS ONE (2021)
Molecular Markers and Targets in Melanoma
Cristina Teixido et al.
CELLS (2021)
The role of homologous recombination deficiency testing in ovarian cancer and its clinical implications: do we need it?
N. Y. L. Ngoi et al.
ESMO OPEN (2021)
ARID3A promotes the development of colorectal cancer by upregulating AURKA
Jing Tang et al.
CARCINOGENESIS (2021)
Harmonization and Standardization of Panel-Based Tumor Mutational Burden Measurement: Real-World Results and Recommendations of the Quality in Pathology Study
Albrecht Stenzinger et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
The repertoire of mutational signatures in human cancer
Ludmil B. Alexandrov et al.
NATURE (2020)
KIT Mutation Incidence and Pattern of Melanoma in Central Europe
V. Doma et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
MUC4 isoforms expression profiling and prognosis value in Chinese melanoma patients
Jinyu Yu et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2020)
The mutational constraint spectrum quantified from variation in 141,456 humans
Konrad J. Karczewski et al.
NATURE (2020)
High mutation load, immune-activated microenvironment, favorable outcome, and better immunotherapeutic efficacy in melanoma patients harboring MUC16/CA125 mutations
Qinghua Wang et al.
AGING-US (2020)
Integrated molecular drivers coordinate biological and clinical states in melanoma
Jake R. Conway et al.
NATURE GENETICS (2020)
Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma
V. Doma et al.
BMC CANCER (2019)
COSMIC: the Catalogue Of Somatic Mutations In Cancer
John G. Tate et al.
NUCLEIC ACIDS RESEARCH (2019)
ClinVar: improving access to variant interpretations and supporting evidence
Melissa J. Landrum et al.
NUCLEIC ACIDS RESEARCH (2018)
The clinical significance of KIT mutations in melanoma: a meta-analysis
Hui Z. Gong et al.
MELANOMA RESEARCH (2018)
A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing
Deng Pan et al.
SCIENCE (2018)
Overexpressing TPTE2 (TPIP), a homolog of the human tumor suppressor gene PTEN, rescues the abnormal phenotype of the PTEN–/– mutant
Daniel F. Lusche et al.
Oncotarget (2018)
Genetic profiling of melanoma in routine diagnostics: assay performance and molecular characteristics in a consecutive series of 274 cases
Jonas Leichsenring et al.
PATHOLOGY (2018)
The international Genome sample resource (IGSR): A worldwide collection of genome variation incorporating the 1000 Genomes Project data
Laura Clarke et al.
NUCLEIC ACIDS RESEARCH (2017)
Analysis of mutant allele fractions in driver genes in colorectal cancer - biological and clinical insights
Rodrigo Dienstmann et al.
MOLECULAR ONCOLOGY (2017)
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers et al.
GENOME MEDICINE (2017)
The calcium-cancer signalling nexus
Gregory R. Monteith et al.
NATURE REVIEWS CANCER (2017)
Identification of Sets of Cytoskeletal Related and Adhesion-related Coding Region Mutations in the TCGA Melanoma Dataset that Correlate with a Negative Outcome
John M. Yavorski et al.
CURRENT GENOMICS (2017)
Genetic Basis for Clinical Response to CTLA-4 Blockade
Ignacio Melero et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
delta-Catenin, a Wnt/beta-catenin modulator, reveals inducible mutagenesis promoting cancer cell survival adaptation and metabolic reprogramming
J. Nopparat et al.
ONCOGENE (2015)
SAMBLASTER: fast duplicate marking and structural variant read extraction
Gregory G. Faust et al.
BIOINFORMATICS (2014)
Chromosome 10, Frequently Lost in Human Melanoma, Encodes Multiple Tumor-Suppressive Functions
Lawrence N. Kwong et al.
CANCER RESEARCH (2014)
Conserved Oncogenic Behavior of the FAM83 Family Regulates MAPK Signaling in Human Cancer
Rocky Cipriano et al.
MOLECULAR CANCER RESEARCH (2014)
Functional and cancer genomics of ASXL family members
M. Katoh
BRITISH JOURNAL OF CANCER (2013)
Identification and Functional Characterization of FMN2, a Regulator of the Cyclin-Dependent Kinase Inhibitor p21
Kayo Yamada et al.
MOLECULAR CELL (2013)
INTERFEROME v2.0: an updated database of annotated interferon-regulated genes
Irina Rusinova et al.
NUCLEIC ACIDS RESEARCH (2013)
Melanoma Genetics: Recent Findings Take Us Beyond Well-Traveled Pathways
Matthew H. Law et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Share Paper
